C. Du

发表

Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD.

S. Knapp, S. Harper, D. Bates, 2013, Investigative ophthalmology & visual science.

Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant

C. Du, J. Hancox, C. Dempsey, 2021, Cellular and molecular life sciences : CMLS.

Structural implications of hERG K+ channel block by a high-affinity minimally structured blocker

C. Du, J. Hancox, C. Dempsey, 2018, The Journal of Biological Chemistry.

Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants

C. Du, J. Hancox, C. Dempsey, 2014, Journal of molecular and cellular cardiology.

Emerging therapeutic targets in the short QT syndrome

Dominic G. Whittaker, C. Du, J. Hancox, 2018, Expert opinion on therapeutic targets.

Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome

C. Du, J. Hancox, Hongwei Cheng, 2019, Journal of molecular and cellular cardiology.

Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform.

C. Du, J. Hancox, A. El Harchi, 2011, Biochemical and biophysical research communications.

A novel genetic modifier for clarithromycin-related cardiac arrhythmia risk?

A. Baranchuk, C. Du, J. Hancox, 2014, Therapeutic advances in infectious disease.

Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant

C. Du, J. Hancox, C. Dempsey, 2021, Cellular and Molecular Life Sciences.

Complementarity between Arrhythmia Mechanisms Found in Silico and in Genetic Models of N588K-hERG Linked Short QT Syndrome

C. Du, J. Hancox, Henggui Zhang, 2020, Journal of Integrative Cardiology Open Access.

Acidosis Impairs the Protective Role of hERG K+ Channels Against Premature Stimulation

Yi H. Zhang, C. Du, J. Hancox, 2010, Journal of cardiovascular electrophysiology.

Modification of KCNH 2-Encoded Cardiac Potassium Channels by KCNE 1 Polymorphism LETTER TO THE

C. Du, J. Hancox, Henggui Zhang, 2014 .

Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.

Jules C Hancox, Stefan Knapp, Jennifer Batson, 2017, ACS chemical biology.

Pharmacological Inhibition of the hERG Potassium Channel Is Modulated by Extracellular But Not Intracellular Acidosis

C. Du, J. Hancox, A. El Harchi, 2011, Journal of cardiovascular electrophysiology.

Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition

C. Du, J. Hancox, Henggui Zhang, 2013, Physiological reports.

Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome

C. Du, J. Hancox, Y. Zhang, 2023, Philosophical Transactions of the Royal Society B.

Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp

G. Bett, C. Du, J. Hancox, 2022, Frontiers in Pharmacology.

High potency inhibition of hERG potassium channels by the sodium–calcium exchange inhibitor KB‐R7943

C. Du, J. Hancox, Hongwei Cheng, 2012, British journal of pharmacology.

Palmitoylation regulates the magnitude of HCN4-mediated currents in mammalian cells

C. Du, J. Hancox, W. Fuller, 2023, Frontiers in Physiology.

Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration

C. Du, J. Hancox, A. El Harchi, 2014, Physiological reports.

Emerging therapeutic targets in the short QT syndrome

Dominic G. Whittaker, C. Du, J. Hancox, 2018, Expert opinion on therapeutic targets.